Logo

personalized medicine

Metastatic Tumor Subtypes Found With Expression Profiling

Researchers unearthed four metastatic tumor molecular subtypes based on gene expression profiles in patient-derived xenograft and human tumor samples.

Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer

The study is evaluating the Guardant Reveal assay to guide chemotherapy treatment decisions following surgery for stage II to III colorectal cancer.

Personalis to Lay off up to 30 Percent of Workforce

The company estimated that the reduction will save it approximately $17 million in operating costs for the remainder of this year.

Estonian Team Building Personalized Medicine Center of Excellence With €30M in National, EU Funding
Premium

Among many objectives, the project will perform whole-genome sequencing of 10,000 individuals to build out its reference genome set.

Caris Life Sciences Taps Juniper Biologics to Market Sequencing Tests in Southeast Asia

The move will make Caris' comprehensive cancer sequencing services available to physicians and patients in the region.

Jan 10, 2023

Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test

Jan 5, 2023

Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response

Dec 22, 2022

Genomic Medicine Adoption May be Hindered by Shortcomings in ICD-10 Coding
Premium

Dec 16, 2022

EU Awards €4.8M to Support Transition of NGS Workflows to Clinical Settings
Premium

Dec 12, 2022

T-Cell Subpopulations in Blood May Help Predict Immune Checkpoint Immunotherapy Side Effects

Dec 9, 2022

Exact Sciences Takes Aim at Radiotherapy Response Prediction With New Gene Expression Data
Premium

Dec 6, 2022

Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement

Nov 28, 2022

OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing

Nov 22, 2022

South Carolina Population Genomics Program Marks First Anniversary With Surge in Participation
Premium

Nov 18, 2022

NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug

Nov 17, 2022

Asa Ren, G42 Healthcare Partner to Promote Genomics, Bioinformatics in Indonesia

Nov 10, 2022

Cancer Patients in Early Trial Receive Personalized, CRISPR-Edited T-Cell Therapy

Nov 8, 2022

SimBioSys Gets $2M NCI Award for Tumor Visualization, Analysis Platform

Nov 7, 2022

Pathologists Evaluate Implementation of PGDx Comprehensive Genomic Profiling Kit
Premium

Oct 24, 2022

Molecular Tumor Board Therapy Matching Predicts Immunotherapy Best Responders
Premium

Sep 27, 2022

GATC Health, Akon Lighting to Generate AI-Driven Genomic Insights From Over 1M Africans

Sep 22, 2022

Cowen Initiates Coverage of 23andMe With Outperform Rating

Sep 21, 2022

Liquid Biopsy Firm Hedera Dx Raises €14M in Seed Funding

Sep 7, 2022

Matched Therapy 'Evidence Scale' Predicts Targeted Treatment Efficacy in Breast Cancer Patients

Sep 7, 2022

Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain
Premium

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.